PH12642A - Indazole derivatives - Google Patents

Indazole derivatives

Info

Publication number
PH12642A
PH12642A PH19181A PH19181A PH12642A PH 12642 A PH12642 A PH 12642A PH 19181 A PH19181 A PH 19181A PH 19181 A PH19181 A PH 19181A PH 12642 A PH12642 A PH 12642A
Authority
PH
Philippines
Prior art keywords
indazole derivatives
indazole
derivatives
Prior art date
Application number
PH19181A
Other languages
English (en)
Inventor
P Neumann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1571675A external-priority patent/CH605934A5/de
Priority claimed from CH1664575A external-priority patent/CH605858A5/de
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH12642A publication Critical patent/PH12642A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH19181A 1975-12-03 1976-12-01 Indazole derivatives PH12642A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1571675A CH605934A5 (en) 1975-12-03 1975-12-03 Myotonolytic oxazolinyl- and thiazolinyl-amino-indazole derivs.
CH1664575A CH605858A5 (en) 1975-12-22 1975-12-22 Myotonolytic oxazolinyl- and thiazolinyl-amino-indazole derivs.
CH927976 1976-07-20
CH931276 1976-07-21

Publications (1)

Publication Number Publication Date
PH12642A true PH12642A (en) 1979-07-11

Family

ID=27429211

Family Applications (1)

Application Number Title Priority Date Filing Date
PH19181A PH12642A (en) 1975-12-03 1976-12-01 Indazole derivatives

Country Status (20)

Country Link
US (1) US4086353A (en:Method)
JP (1) JPS5268177A (en:Method)
AU (1) AU510820B2 (en:Method)
BE (1) BE848962A (en:Method)
CA (1) CA1082714A (en:Method)
DE (1) DE2653005A1 (en:Method)
DK (1) DK528976A (en:Method)
ES (1) ES453861A1 (en:Method)
FI (1) FI763385A7 (en:Method)
FR (1) FR2333504A1 (en:Method)
GB (1) GB1564327A (en:Method)
IE (1) IE44316B1 (en:Method)
IL (1) IL51028A (en:Method)
NL (1) NL7613317A (en:Method)
NO (1) NO764039L (en:Method)
NZ (1) NZ182779A (en:Method)
PH (1) PH12642A (en:Method)
PT (1) PT65918B (en:Method)
SE (1) SE424553B (en:Method)
YU (1) YU293876A (en:Method)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57501378A (en:Method) * 1980-09-05 1982-08-05
ES2380054T3 (es) * 2001-09-26 2012-05-08 Pfizer Italia S.R.L. Derivados de aminoindazol activos como inhibidores de quinasas, procedimientos para su preparación, y composiciones farmacéuticas que los contienen
SE0402762D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Indazole sulphonamide derivatives
SE0402763D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Nitro indazole derivatives
BRPI0618668B1 (pt) * 2005-11-15 2021-09-21 Array Biopharma Inc Compostos inibidores dos receptores de tirosina quinase do tipo i, composições compreendendo tais compostos, e seus usos
JP2009520825A (ja) * 2005-12-20 2009-05-28 武田薬品工業株式会社 グルコキナーゼ活性剤
BRPI0815154B1 (pt) 2007-08-17 2024-01-30 Lg Chem, Ltd Compostos de indol, composição, e, método de preparação da mesma
KR101098583B1 (ko) * 2008-01-04 2011-12-26 주식회사 엘지생명과학 세포, 조직 및 장기 보존 효과를 갖는 인돌 및 인다졸 유도체
KR101404151B1 (ko) * 2011-11-25 2014-06-05 가톨릭대학교 산학협력단 안과 질환의 예방 및 치료용 약학 조성물
WO2016115272A1 (en) 2015-01-13 2016-07-21 Vanderbilt University Benzothiazole and benzisothiazole-substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
WO2016115282A1 (en) 2015-01-13 2016-07-21 Vanderbilt University Benzoisoxazole-substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
WO2016123629A1 (en) 2015-01-30 2016-08-04 Vanderbilt University Indazole and azaindazole substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759903A (en) * 1971-07-28 1973-09-18 Squibb & Sons Inc Thiazolinyl and thiazinyl derivatives of indazoles

Also Published As

Publication number Publication date
IE44316L (en) 1977-06-03
AU510820B2 (en) 1980-07-17
CA1082714A (en) 1980-07-29
GB1564327A (en) 1980-04-10
FR2333504B1 (en:Method) 1980-08-29
ES453861A1 (es) 1978-03-01
IL51028A0 (en) 1977-02-28
PT65918B (fr) 1978-07-05
NZ182779A (en) 1979-08-31
JPS5268177A (en) 1977-06-06
DK528976A (da) 1977-06-04
IL51028A (en) 1980-06-30
NL7613317A (nl) 1977-06-07
AU2025276A (en) 1978-06-08
IE44316B1 (en) 1981-10-21
US4086353A (en) 1978-04-25
DE2653005A1 (de) 1977-06-08
PT65918A (fr) 1977-01-01
SE424553B (sv) 1982-07-26
FR2333504A1 (fr) 1977-07-01
NO764039L (en:Method) 1977-06-06
BE848962A (fr) 1977-06-01
YU293876A (en) 1982-05-31
FI763385A7 (en:Method) 1977-06-04
SE7613195L (sv) 1977-06-04

Similar Documents

Publication Publication Date Title
JPS5273886A (en) Piperidylltriazine derivatives
GB1550160A (en) 4-hydroxypyrrolidin-2-one derivatives
GB1520812A (en) Benzhydrylsulphinyl derivatives
IL48209A0 (en) Amidinourea derivatives
IL49706A (en) Anhydro-vinca derivatives
PH12642A (en) Indazole derivatives
AU1597876A (en) Ortho-aminobutyrophenone derivatives
GB1540845A (en) 6-oxo-pyrimidine derivatives
IL59758A0 (en) -amino- , -bis-carobxy-alkane derivatives
AU1074176A (en) Oxadiazolinone derivatives
MY8300054A (en) Cis-bicyclooctyl-alkyl-amine derivatives
IE44308L (en) Androsten-17-one derivatives
GB1486104A (en) Phthalimidopiperidine derivatives
IL49102A0 (en) Triazolobenzocycloalkylthiadiazine derivatives
JPS5248661A (en) 22methoxyybenzamide derivatives
JPS5248672A (en) Thiazolinylaminoopiperidine derivatives
GB1554720A (en) Pyridthione derivatives
AU1661376A (en) Morphanthridine derivatives
GB1545577A (en) N-alkyl-3-phenylisoxazole-4-carboxamide derivatives
JPS5246057A (en) Dicaboxylacte derivatives
GB1520011A (en) Benodioxole derivatives
JPS5273892A (en) Azethizinone derivatives
IL49072A0 (en) Triazolocycloalkylthiadiazine derivatives
GB1520682A (en) Monochloro-striazine derivatives
JPS5283398A (en) Azethidinone derivatives